BAP1 MUTATIONS IN MALIGNANT PLEURAL MESOTHELIOMA: BIOLOGY, CLINICAL PHENOTYPES, RADIOTHERAPY RESPONSE, AND TARGET DISCOVERY FOR SOMATIC AND GERMLINE

Sloan-Kettering Institute For Cancer Research

Investigators